ALB
BEARISH
$189.51
Live
Albemarle Corporation · NYSE
Target $165.06
(-12.9%)
$49.43
52W Range
$191.97
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$22.3B
P/E
N/A
ROE
0.2%
Profit margin
-0.4%
Debt/Equity
0.37
Dividend yield
0.86%
AI Analysis
AI-powered fundamental assessment
Confidence
78%
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in fundamental performance. Despite a strong recent price run-up (+115.4% over 1Y), the company is unprofitable (negative profit and operating margins), has negative earnings growth (YoY), and trades at an extremely high forward P/E of 82.85. While the balance sheet shows a healthy current ratio and manageable debt/equity of 0.37, the lack of Altman Z-Score and Graham Number, combined with deteriorating profitability and insider selling, raises serious concerns about sustainability. The analyst target price of $165.06 implies 13% downside from current levels, reinforcing overvaluation relative to fundamentals.
Key Strengths
Strong short-term liquidity with current ratio of 2.27 and quick ratio of 1.38
Low debt/equity ratio of 0.37, indicating conservative capital structure
Recent earnings surprises have been positive on average over the last four quarters (+88.45%)
Dividend payout ratio of 57.97% is sustainable for now given stable cash flows
Significant year-to-date price momentum (+128.2% over 6M) suggests strong market sentiment
Key Risks
Critically low Piotroski F-Score of 2/9 signals severe financial distress and deteriorating operational performance
Negative profit margin (-0.43%) and operating margin (-2.24%) indicate core business unprofitability
Extremely high forward P/E of 82.85 suggests substantial overvaluation relative to earnings power
Most recent Q/Q EPS growth is -272.7%, reflecting a sharp earnings collapse
Insider selling activity and bearish technical trend (10/100) signal lack of confidence from insiders and weak price momentum near 52-week high
AI Fair Value Estimate
Based on comprehensive analysis
$120.0
-36.7% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
34
Weak
25
30
45
20
50
AI Verdict
Overvalued with deteriorating fundamentals and high risk
Key drivers: Low Piotroski F-Score (2/9), Negative profitability metrics, High forward P/E ratio, Recent insider selling, Negative Q/Q earnings growth
Confidence
80%
Value
25/100
Ref P/E, PEG, Graham Number
Positives
- Price/Book of 2.87 below sector average P/E of 37.04 (though not directly comparable)
Watchpoints
- Forward P/E of 82.85 is extremely high
- No Graham Number or Intrinsic Value available
- Stock trades at significant premium to estimated fair value
Future
30/100
Ref Growth rates
Positives
- Analyst target implies some upside potential (though below current price)
- Sector tailwinds in specialty chemicals and lithium demand may support long-term growth
Watchpoints
- Revenue growth YoY is -3.50%
- Q/Q EPS growth is -272.7%
- No reliable earnings growth trajectory
Past
45/100
Ref Historical trends
Positives
- History of strong earnings beats in prior years (e.g., +62.2% in 2023-Q3)
- Positive 1Y and 6M price returns (+115.4%, +128.2%)
Watchpoints
- Recent quarters show deep losses and large negative surprises
- Profitability has sharply declined since 2023
Health
20/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Current ratio of 2.27 indicates short-term liquidity strength
- Debt/equity of 0.37 is low and manageable
Watchpoints
- Piotroski F-Score of 2/9 indicates critical financial weakness
- ROE of 0.21% and ROA of 0.14% are near zero
- No Altman Z-Score available, increasing uncertainty
Dividend
50/100
Ref Yield, Payout
Positives
- Dividend yield of 0.86% provides minor income support
- Payout ratio of 57.97% is within acceptable range
Watchpoints
- Dividend strength score of 40/100 indicates weak reliability
- Unprofitable company paying dividends raises sustainability concerns
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$189.51
Analyst Target
$165.06
Upside/Downside
-12.9%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ALB and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ALB
Albemarle Corporation
Primary
|
+13.7% | -25.1% | +115.4% | +128.2% | +27.6% | +16.2% |
|
RGLD
Royal Gold, Inc.
Peer
|
+142.6% | +99.0% | +46.3% | +38.9% | +10.8% | +0.5% |
|
CDE
Coeur Mining, Inc.
Peer
|
+97.8% | +427.6% | +230.7% | +3.5% | +8.2% | -5.2% |
|
PPG
PPG Industries, Inc.
Peer
|
-29.3% | -15.9% | +9.9% | +6.0% | +6.2% | -3.9% |
|
DD
DuPont de Nemours, Inc.
Peer
|
+56.6% | +63.1% | +50.5% | +42.5% | -6.9% | -0.3% |
ALB
Albemarle Corporation
Primary
5Y
+13.7%
3Y
-25.1%
1Y
+115.4%
6M
+128.2%
1M
+27.6%
1W
+16.2%
RGL
Royal Gold, Inc.
Peer
5Y
+142.6%
3Y
+99.0%
1Y
+46.3%
6M
+38.9%
1M
+10.8%
1W
+0.5%
CDE
Coeur Mining, Inc.
Peer
5Y
+97.8%
3Y
+427.6%
1Y
+230.7%
6M
+3.5%
1M
+8.2%
1W
-5.2%
PPG
PPG Industries, Inc.
Peer
5Y
-29.3%
3Y
-15.9%
1Y
+9.9%
6M
+6.0%
1M
+6.2%
1W
-3.9%
DD
DuPont de Nemours, Inc.
Peer
5Y
+56.6%
3Y
+63.1%
1Y
+50.5%
6M
+42.5%
1M
-6.9%
1W
-0.3%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
82.85
PEG Ratio
N/A
P/B Ratio
2.87
P/S Ratio
4.51
EV/Revenue
5.39
EV/EBITDA
38.23
Market Cap
$22.3B
Profitability
Profit margins and return metrics
Profit Margin
-0.43%
Operating Margin
-2.24%
Gross Margin
12.39%
ROE
0.21%
ROA
0.14%
Growth
Revenue and earnings growth rates
Revenue Growth
-3.5%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.37
Low debt
Current Ratio
2.27
Strong
Quick Ratio
1.38
Good
Cash/Share
$16.41
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-11
$N/A
2025-11-05
$-0.19
+78.3% surprise
2025-07-30
$0.11
+113.5% surprise
2025-04-30
$-0.18
+73.5% surprise
Basic Materials Sector Comparison
Comparing ALB against 143 companies in the Basic Materials sector
(14 bullish, 54 neutral, 75 bearish)
Return on Equity (ROE)
0.21%
This Stock
vs
-6.64%
Sector Avg
-103.1%
(Below Avg)
Profit Margin
-0.43%
This Stock
vs
-5.75%
Sector Avg
-92.6%
(Weaker)
Debt to Equity
0.37
This Stock
vs
0.89
Sector Avg
-58.8%
(Less Debt)
Revenue Growth
-3.5%
This Stock
vs
36.56%
Sector Avg
-109.6%
(Slower)
Current Ratio
2.27
This Stock
vs
5.16
Sector Avg
-56.0%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ALB
Albemarle Corporation
|
BEARISH | $22.3B | - | 0.2% | -0.4% | $189.51 | |
|
RGLD
Royal Gold, Inc.
|
NEUTRAL | $22.75B | 40.02 | 9.1% | 45.6% | $268.12 | Compare |
|
CDE
Coeur Mining, Inc.
|
NEUTRAL | $19.99B | 20.33 | 26.4% | 28.3% | $19.31 | Compare |
|
PPG
PPG Industries, Inc.
|
NEUTRAL | $24.68B | 15.94 | 21.1% | 9.9% | $110.3 | Compare |
|
DD
DuPont de Nemours, Inc.
|
BEARISH | $19.36B | 220.05 | 0.5% | -11.4% | $46.21 | Compare |
ALB
Albemarle Corporation
BEARISH
Mkt Cap
$22.3B
P/E
-
ROE
0.2%
Price
$189.51
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-06 | SHEOREY NEAL RAVI | Chief Financial Officer | Stock Award | 1,953 | - |
| 2025-10-24 | KRUPA ANDER C | General Counsel | Sale | 172 | $18,060 |
| 2025-10-09 | KRUPA ANDER C | General Counsel | Sale | 116 | $11,020 |
| 2025-08-06 | KRUPA ANDER C | General Counsel | Stock Award | 7,430 | - |
SHEOREY NEAL RAVI
Chief Financial Officer
2025-11-06
1,953 shares
KRUPA ANDER C
General Counsel
2025-10-24
172 shares
·
$18,060
KRUPA ANDER C
General Counsel
2025-10-09
116 shares
·
$11,020
KRUPA ANDER C
General Counsel
2025-08-06
7,430 shares
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
23 analysts
Citigroup
2026-01-21
Neutral
Neutral
Oppenheimer
2026-01-21
Outperform
Outperform
Truist Securities
2026-01-21
Hold
Buy
Deutsche Bank
2026-01-13
Hold
Buy
UBS
2026-01-12
Buy
Buy
Mizuho
2026-01-12
Neutral
Neutral
Scotiabank
2026-01-12
Sector Perform
Sector Outperform
Baird
2026-01-07
Neutral
Outperform
Jefferies
2026-01-06
Buy
Buy
Wells Fargo
2025-12-19
Equal-Weight
Equal-Weight
Past News Coverage
Recent headlines mentioning ALB from our newsroom.
Newest → oldest
No matching news yet.